TRIM33 and dermatomyositis: Anti-TIF1γ antibody was detected in both adult DM and JDM patients and was closely correlated with malignancies, especially in elderly patients18–20, at high risk of dysphagia21 and at low risk of ILD, Raynaud phenomenon, and arthritis/arthralgia22.